Maohua Chen
ORCID: 0000-0002-0812-2729
· 1 paper in corpus
Tamoxifen (TAM), a selective estrogen receptor (ER) modulator, has received approval for use in patients with breast cancer (BC) exhibiting positive ER expression. Given the widespread clinical use of TAM, a comprehensive real-world study o…